Scarica l'app Stockscreener
15.70
40.77%
-10.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Precedente Chiudi:
$26.12
Aprire:
$16
Volume 24 ore:
2.70M
Relative Volume:
4.41
Capitalizzazione di mercato:
$602.60M
Reddito:
$128.29M
Utile/perdita netta:
$-30.69M
Rapporto P/E:
-19.15
EPS:
-0.82
Flusso di cassa netto:
$-27.17M
1 W Prestazione:
-41.99%
1M Prestazione:
-42.55%
6M Prestazione:
-67.67%
1 anno Prestazione:
-69.81%
Intervallo 1D:
$14.37
$16.24
Intervallo di 1 settimana:
$14.37
$26.81
Portata 52W:
$14.37
$66.54
Rxsight Inc Stock (RXST) Company Profile
Nome
Rxsight Inc
Settore
Industria
Telefono
949-521-7822
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Confronta RXST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
15.50 | 602.60M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
132.06 | 229.74B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
98.88 | 145.53B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
362.76 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.84 | 114.37B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.97 | 42.24B | 5.72B | 4.17B | 259.90M | 6.97 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-20 | Downgrade | Stifel | Buy → Hold |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-10-29 | Iniziato | Jefferies | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-05-07 | Reiterato | BTIG Research | Buy |
| 2023-12-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Iniziato | Morgan Stanley | Overweight |
| 2023-04-13 | Iniziato | Oppenheimer | Outperform |
| 2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Iniziato | Needham | Buy |
Mostra tutto
Rxsight Inc Borsa (RXST) Ultime notizie
RxSight Faces Market Challenges As Revenue Guidance Drops - Finimize
RxSight Inc. (RXST) PT Lowered to $28 at BTIG - StreetInsider
BofA cuts RxSight stock rating, price target to $22 from $36 - Investing.com
Stifel maintains RxSight stock hold, price target at $28 - Investing.com
RxSight plunges after guidance cut; BofA downgrades - MSN
Earnings call transcript: RxSight Q1 2025 sees revenue growth, stock dips - Investing.com
RxSight stock down after guidance cut (update) (RXST:NASDAQ) - Seeking Alpha
Sector Update: Health Care - MarketScreener
Needham maintains Buy on RxSight stock, price target at $43 - Investing.com India
BofA Securities Downgrades RxSight Inc. (RXST) to Underperform - StreetInsider
RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges - Yahoo Finance
Needham Reiterates Buy Rating on RxSight Inc. (RXST) - StreetInsider
HighTower Advisors LLC Lowers Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight Preliminary Q1 Revenue Increases; Lowers 2025 Revenue Guidance - MarketScreener
RxSight, Inc. Provides Revenue Guidance for the First Quarter 2025 - MarketScreener
RxSight Expects 28% Growth In Q1 Revenue; Cuts FY25 Revenue Outlook - Nasdaq
RxSight Cuts 2025 Revenue Target by $25M Despite Strong Lens Sales Growth - Stock Titan
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance - Bluefield Daily Telegraph
(RXST) Trading Report - news.stocktradersdaily.com
RxSight, Inc. (NASDAQ:RXST) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
BofA sees Bausch + Lomb IOL recall news as positive for RxSight - MSN
Midday Stock Roundup: Boot Barn, Beta Bionics down - Orange County Business Journal
RxSight, Inc. (NASDAQ:RXST) Shares Bought by Swiss National Bank - Defense World
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Jefferies starts coverage on Rxsight with 'buy' on growth potential - TradingView
RxSight, Inc. (NASDAQ:RXST) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Bank of America Issues Pessimistic Forecast for RxSight (NASDAQ:RXST) Stock Price - Defense World
Where are the Opportunities in (RXST) - news.stocktradersdaily.com
BofA cuts RxSight stock price target to $36, maintains Buy rating - Investing.com Canada
RxSight price target lowered to $36 from $60 at BofA - TipRanks
BofA cuts RxSight stock price target to $36, maintains Buy rating By Investing.com - Investing.com South Africa
RxSight Inc. (RXST) PT Lowered to $36 at BofA Securities - StreetInsider.com
Stifel Nicolaus Lowers RxSight (NASDAQ:RXST) Price Target to $28.00 - Defense World
RxSight (NASDAQ:RXST) Hits New 52-Week Low on Analyst Downgrade - Defense World
RxSight stock plunges to 52-week low at $24.48 amid market shifts - Investing.com Australia
RxSight stock plunges to 52-week low at $24.48 amid market shifts By Investing.com - Investing.com South Africa
Bank of New York Mellon Corp Increases Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
Stifel cuts RxSight stock price target to $28 from $33 By Investing.com - Investing.com Canada
Stifel cuts RxSight stock price target to $28 from $33 - Investing.com
The Analyst Verdict: RxSight In The Eyes Of 9 Experts - Benzinga
RxSight Inc. (RXST) PT Lowered to $28 at Stifel - StreetInsider.com
RxSight price target lowered to $28 from $33 at Stifel - TipRanks
RxSight director Tamara Fountain sells $180,001 in company stock - Investing.com India
Victory Capital Management Inc. Raises Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
Investment Analysts’ Recent Ratings Updates for RxSight (RXST) - Defense World
RxSight director Tamara Fountain sells $180,001 in company stock By Investing.com - Investing.com Australia
RxSight, Inc. (NASDAQ:RXST) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless - Simply Wall St
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Principal Financial Group Inc. Purchases 3,879 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Rhumbline Advisers Boosts Stake in RxSight, Inc. (NASDAQ:RXST) - Defense World
Rxsight Inc Azioni (RXST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.62%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):